- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
AVEO Pharmaceuticals Inc
+ Add to WatchlistAVEO:US
2.5500 USD 0.0700 2.67%As of 17:20:00 ET on 06/19/2013.
Company Profile for AVEO Pharmaceuticals Inc (AVEO)
Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.
Contact Information
AVEO Pharmaceuticals Inc
75 Sidney Street
Cambridge, MA 02139
United States
Key Executives for AVEO Pharmaceuticals Inc (AVEO)
| Tuan Ha-NgocPresident/CEO | David B JohnstonChief Financial Officer |
| William SlichenmyerChief Medical Officer | Michael P BaileyChief Commercial Officer |
| Elan EzicksonExec VP/COO | Joseph VittiglioSenior VP/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page